Orchestra BioMed Holdings, Inc. financial data

Symbol
OBIO on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
150 Union Square Drive, New Hope, Pennsylvania
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Health Sciences Acquisitions Corp 2 (to 1/26/2023)
Latest financial report
Q1 2024 - May 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 719 % +10%
Quick Ratio 1.05 %
Debt-to-equity 66.2 %
Return On Equity -70.2 % -28%
Return On Assets -49.2 % -46.3%
Operating Margin -2.45 K % -141%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 35.8 M shares +0.06%
Common Stock, Shares, Outstanding 35.8 M shares +12.7%
Entity Public Float 123 M USD -22.7%
Common Stock, Value, Issued 4 K USD +33.3%
Weighted Average Number of Shares Outstanding, Basic 35.8 M shares +29.4%
Weighted Average Number of Shares Outstanding, Diluted 35.8 M shares +29.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.22 M USD -42.2%
Cost of Revenue 176 K USD -17.4%
Research and Development Expense 34.7 M USD +29.8%
General and Administrative Expense 2.96 M USD +977%
Costs and Expenses 56.6 M USD +31.9%
Operating Income (Loss) -54.4 M USD -39.2%
Net Income (Loss) Attributable to Parent -51.6 M USD -33%
Earnings Per Share, Basic -1.46 USD/shares +27.7%
Earnings Per Share, Diluted -1.46 USD/shares +27.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 23.3 M USD +24.8%
Marketable Securities, Current 51.7 M USD -52.3%
Accounts Receivable, after Allowance for Credit Loss, Current 67 K USD -11.8%
Inventory, Net 115 K USD -50.4%
Assets, Current 76.4 M USD -41.2%
Property, Plant and Equipment, Net 1.31 M USD -9.91%
Operating Lease, Right-of-Use Asset 1.5 M USD -26.1%
Assets 82.6 M USD -39.4%
Accounts Payable, Current 3.35 M USD +21.3%
Employee-related Liabilities, Current 994 K USD +9.35%
Accrued Liabilities, Current 3.53 M USD +8.29%
Liabilities, Current 10.4 M USD -13.6%
Deferred Income Tax Liabilities, Net 508 K USD -20.3%
Operating Lease, Liability, Noncurrent 1.16 M USD -22.7%
Other Liabilities, Noncurrent 266 K USD
Liabilities 25.4 M USD -30.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -8 K USD +77.1%
Retained Earnings (Accumulated Deficit) -262 M USD -24.5%
Stockholders' Equity Attributable to Parent 99.8 M USD +127788%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 57.2 M USD -42.7%
Liabilities and Equity 82.6 M USD -39.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.1 M USD +8.81%
Net Cash Provided by (Used in) Financing Activities 56.8 M USD +129%
Net Cash Provided by (Used in) Investing Activities 5.86 M USD
Common Stock, Shares Authorized 340 M shares 0%
Common Stock, Shares, Issued 35.8 M shares +12.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.24 M USD -564%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 23.3 M USD +24.8%
Deferred Tax Assets, Valuation Allowance 60.1 M USD +29.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.5 pure
Deferred Tax Assets, Gross 60.6 M USD +28.8%
Operating Lease, Liability 1.62 M USD -26.5%
Depreciation 290 K USD +18.4%
Payments to Acquire Property, Plant, and Equipment 8 K USD -77.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -51.6 M USD -32.8%
Lessee, Operating Lease, Liability, to be Paid 1.95 M USD
Property, Plant and Equipment, Gross 2.38 M USD +3.35%
Operating Lease, Liability, Current 465 K USD -34.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 464 K USD -36.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 339 K USD -45.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +48%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 323 K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 476 K USD +35.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 159 K USD -54.8%
Operating Lease, Payments 228 K USD +11.2%
Additional Paid in Capital 320 M USD +2.92%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 74 K USD +4.23%
Deferred Tax Assets, Net of Valuation Allowance 508 K USD -20.3%
Operating Leases, Future Minimum Payments Due 2.49 M USD
Interest Expense 351 K USD +48.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%